看空
Pain medicine that is going to hurt

Ktov has blown up over 113% in the last several days. While its hard to do technical analysis on a stock that is sub a dollar, Im going to make it anyways for a friend.
Given the past trends after massive spikes, I would expect the slight downtrend to last another day.
The massive buying volumes coming in over the past 2 days also indicate that people are being sold into heavily.
I believe the boat has been missed if you wanted to get rich off of this stock. All bios are hot right now and it would only make sense that a company who is dealing in the single digit millions of funding is not going anywhere fast.
I believe there is strong correlation between the IPO that happened a month ago where 20MM shares were offered at $0.30 a share.
If people really believed this was going to be huge, they would have bought the stock back in may 2018 when the drug was first approved by the FDA.
barrons.com/press-release/kitov-closes-6-0-million-public-offering-01584446766?tesla=y&tesla=y
seekingalpha.com/news/3576290-kitov-launches-consensi-in-u-s
Nothing more than a pump and dump
Given the past trends after massive spikes, I would expect the slight downtrend to last another day.
The massive buying volumes coming in over the past 2 days also indicate that people are being sold into heavily.
I believe the boat has been missed if you wanted to get rich off of this stock. All bios are hot right now and it would only make sense that a company who is dealing in the single digit millions of funding is not going anywhere fast.
I believe there is strong correlation between the IPO that happened a month ago where 20MM shares were offered at $0.30 a share.
If people really believed this was going to be huge, they would have bought the stock back in may 2018 when the drug was first approved by the FDA.
barrons.com/press-release/kitov-closes-6-0-million-public-offering-01584446766?tesla=y&tesla=y
seekingalpha.com/news/3576290-kitov-launches-consensi-in-u-s
Nothing more than a pump and dump
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。